Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Assets: 2023-2024

Historic Assets for Zhengye Biotechnology Holding (ZYBT) over the last 2 years, with Dec 2024 value amounting to $68.6 million.

  • Zhengye Biotechnology Holding's Assets fell 2.67% to $67.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $67.6 million, marking a year-over-year decrease of 2.67%. This contributed to the annual value of $68.6 million for FY2024, which is 2.95% down from last year.
  • Latest data reveals that Zhengye Biotechnology Holding reported Assets of $68.6 million as of FY2024, which was down 2.95% from $70.7 million recorded in FY2023.
  • In the past 5 years, Zhengye Biotechnology Holding's Assets ranged from a high of $70.7 million in FY2023 and a low of $68.6 million during FY2024.
  • Over the past 2 years, Zhengye Biotechnology Holding's median Assets value was $69.7 million (recorded in 2024), while the average stood at $69.7 million.
  • Data for Zhengye Biotechnology Holding's Assets shows a maximum YoY decreased of 2.95% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Zhengye Biotechnology Holding's Assets stood at $70.7 million in 2023, then decreased by 2.95% to $68.6 million in 2024.